Department of Digestive Diseases, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Turk J Gastroenterol. 2021 Nov;32(11):979-987. doi: 10.5152/tjg.2020.20841.
Postoperative pancreatic fistula (POPF) is the most frequent and harmful complication following pancreatic surgery. Traditional management includes conservative treatment, percutaneous drainage (PD), and reoperation. The objective of the present study was to evaluate the safety and effectiveness of EUS (Endoscopic ultrasound)-guided drainage by using nasocystic tubes combined with single or 2 stents for POPF.
Patients who had POPF after surgery and then underwent EUS-guided drainage, from October 2016 to October 2019, were enrolled in this study. Technical success was defined as successful transgastric puncture of the peripancreatic fluid collection (PFC) and deployment of the nasocystic tube and stents. Clinical success was defined as symptomatic improvement and the resolution of the fluid collection on follow-up CT scan.
A total of 15 patients received EUS-guided drainage. In 13 patients, a nasocystic tube was placed in the PFC combined with a double-pigtail plastic stent. In the remaining 2 patients, a nasocystic tube and 2 stents each were inserted in place. Technical success was achieved in 15 of 15 patients (100%). Clinical success was achieved in 14 of 15 patients (93.3%). In one case, the stent was blocked on the 10th day after the procedure. The median time between surgery and EUS-guided drainage was 10 (5-32) days. The median time of hospital stay after EUS-guided drainage was 16 (11-48) days. Operation-unrelated death occurred in 1 patient (7%) during follow-up.
EUS-guided drainage with a nasocystic tube and double-pigtail stents appears to be safe and technically feasible, and could be an alternative treatment for patients with POPF.
术后胰瘘(POPF)是胰腺手术后最常见和最有害的并发症。传统的治疗方法包括保守治疗、经皮引流(PD)和再次手术。本研究的目的是评估超声内镜(EUS)引导下经鼻引流管联合单或双支架治疗胰瘘的安全性和有效性。
本研究纳入了 2016 年 10 月至 2019 年 10 月手术后发生胰瘘并接受 EUS 引导下引流的患者。技术成功定义为经胃穿刺成功引流胰周积液(PFC)并放置鼻引流管和支架。临床成功定义为症状改善和随访 CT 扫描显示积液吸收。
共 15 例患者接受了 EUS 引导下引流。在 13 例患者中,在 PFC 中放置了鼻引流管,并联合使用双猪尾塑料支架。在其余 2 例患者中,分别放置了鼻引流管和 2 个支架。15 例患者均达到技术成功(100%)。14 例患者达到临床成功(93.3%)。1 例患者在术后第 10 天支架堵塞。EUS 引导下引流与手术的中位时间间隔为 10(5-32)天。EUS 引导下引流后中位住院时间为 16(11-48)天。随访期间 1 例患者(7%)因手术无关原因死亡。
EUS 引导下经鼻引流管联合双猪尾支架治疗胰瘘安全可行,可能是治疗胰瘘的一种替代方法。